Anzeige
Mehr »
Donnerstag, 26.02.2026 - Börsentäglich über 12.000 News
Winzig bewertet - und jetzt startet die heiße Phase mit Trigger-Fahrplan 2026
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

BioTrackTHC Named Washington State's Legal Marijuana Traceability System

OLYMPIA, Wash., Oct. 21, 2013 /PRNewswire/ --The Washington State Liquor Control Board (WSLCB) has selected BioTrackTHC, a division of Bio-Tech Medical Software, Inc., to provide a legal marijuana traceability system to the agency.

(Logo: http://photos.prnewswire.com/prnh/20131021/FL01138LOGO )

Accurately tracking marijuana throughout the entire supply chain is a major public safety component of the newly passed Washington legislation, Initiative 502. BioTrackTHC's traceability system will assist the WSLCB with tracking and monitoring all marijuana growth, processing, testing, and retail transaction data by marijuana licensees through the supply chain to help prevent diversion, promote public safety, and collect tax revenue. BioTrackTHC was among the 785 vendors the WSLCB directly notified about the contract opportunity; and out of 22 total proposals submitted, BioTrackTHC was the highest scoring bidder for this historic contract: 1041.65 out of a possible 1200.

"We are absolutely thrilled," says Steven Siegel, CEO of BioTrackTHC. "We are very grateful to all of our existing clients, partners, and other industry friends who have given us invaluable feedback and insights into making BioTrackTHC the most robust and accurate seed-to-sale system on the market. We believe that our win is a win for the industry as a whole. Legal marijuana supporters and detractors alike support technology that brings transparency, accountability, and security to the industry."

BioTrackTHC's commercial seed-to-sale inventory tracking software has proven wildly popular within the legal marijuana industry and is currently utilized in nearly 200 medical marijuana producer, processor, and retailer operations across the United States and Canada. Gathering real-time location, growth-phase, production-phase, transportation, disposition, and point-of-sale data, BioTrackTHC's system is the most accurate seed-to-sale system on the market today.

An added benefit for those in Washington already using BioTrackTHC's commercial application to run their marijuana operations is that all of the WSLCB's periodic inventory reporting requirements will be automatically submitted - eliminating the need for time consuming and error-prone manual or double data entry.

"Our selection as Washington State's seed-to-sale traceability system provider further defines BioTrackTHC as the nation's leading provider of legal marijuana inventory tracking solutions," says Mr. Siegel. "Our software simplifies and facilitates compliance for producers, processors, and retailers, while providing those businesses all of the tools they need to run a successful, profitable enterprise. The Washington contract represents a huge opportunity for BioTrackTHC to accelerate its already rapid growth - both in its market share and its revenues."

About Washington State Liquor Control Board

The Washington State Liquor Control Board's mission is to promote public safety by consistent and fair administration of liquor and cannabis laws through education, voluntary compliance, responsible sales and preventing the misuse of alcohol, cannabis and tobacco.http://www.liq.wa.gov.

About BioTrackTHC

For more information and to order the software, contact BioTrackTHC, (tel) 1-800-797-4711, sales@biotrackthc.com, www.biotrackthc.com.

About BioTrackTHC and Bio-Tech Medical Software, Inc.
Bio-Tech Medical Software, Inc., through its BioTrackTHC division, provides effective and cutting-edge technology solutions for the emerging legal marijuana industry that (1) prevents product theft and combats marijuana diversion; (2) assists legal marijuana operators with running their businesses more efficiently, effectively, and to better comply with the law; (3) and facilitates the accountability, transparency, and overall legitimacy of the legal marijuana industry at large. Specifically, BioTrackTHC is the nation's most accurate seed-to-sale software system with enterprise resource planning, complete inventory tracking, point-of-sale, marketing, financial reporting and regulatory compliance features.

Bio-Tech Medical Software, Inc. is a privately-held company, based in Fort Lauderdale, Florida.

This Press Release is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities in the Company or any related or associated company.

Contact: Steven Siegel, CEO, 800-797-4711

SOURCE BioTrackTHC

© 2013 PR Newswire
Tech-Aktien schwanken – 3 Versorger mit Rückenwind
Die Stimmung an den Märkten hat sich grundlegend gedreht. Während Tech- und KI-Werte zunehmend mit Volatilität und Bewertungsrisiken kämpfen, erleben klassische Versorger ein unerwartetes Comeback. Laut IEA und EIA steigt der globale Strombedarf strukturell weiter, nicht nur wegen E-Mobilität und Wärmepumpen, sondern vor allem durch energiehungrige KI-Rechenzentren. Energie wird damit zur zentralen Infrastruktur des digitalen Zeitalters.

Gleichzeitig rücken in unsicheren Marktphasen stabile Cashflows, solide Bilanzen und regulierte Renditen wieder stärker in den Fokus. Genau hier spielen Versorger ihre Stärken aus: berechenbare Erträge, robuste Nachfrage und hohe Dividenden – Qualitäten, die vielen Wachstumswerten aktuell fehlen.

Nach Jahren im Schatten der Tech-Rallye steigt nun das Interesse an Unternehmen, die Stabilität mit langfristigen Wachstumsthemen wie Netzausbau, Dekarbonisierung und erneuerbaren Energien verbinden.

Im aktuellen Spezialreport stellen wir drei Versorger vor, die defensive Stärke mit attraktivem Potenzial kombinieren.

Jetzt den kostenlosen Report sichern – bevor die nächste Versorgerwelle Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.